Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism

James F. Morley, Stephanie M. Pawlowski, Adhithi Kesari, Ivy Maina, Alexander Pantelyat, John E. Duda

Research output: Contribution to journalArticle

Abstract

Background: Drug-induced Parkinsonism is common, causes significant morbidity, and can be clinically indistinguishable from idiopathic Parkinson's disease. Additionally, drug-induced Parkinsonism may, in some cases, represent "unmasking" of incipient Parkinson's disease. Clinical features or tests that distinguish degenerative from pharmacologic Parkinsonism are needed. Methods: We performed a retrospective case-control study of 97 drug-induced Parkinsonism subjects and 97 age-matched patients with Parkinson's disease. We compared the frequency of subjective motor and non-motor complaints, objective motor findings (Unified Parkinson's Disease Rating Scale Part III) and, where available, objective olfactory tests. We also performed a nested case-control study wherein we compared these same features between drug-induced Parkinsonism patients based on whether or not they recovered after changing the offending agent. Results: Non-motor symptoms including constipation and sexual dysfunction were more common in Parkinson's disease than in drug-induced Parkinsonism. While total motor scores were similar between groups, Postural Instability-Gait Difficulty scores were also higher in Parkinson's disease. Features that were significantly different or showed a trend towards significance in both comparisons included subjective loss of facial expression, dream-enactment behavior, autonomic complaints and Postural Instability-Gait Difficulty scores. Hyposmia was more common in Parkinson's disease and was strongly predictive of persistent drug-induced Parkinsonism after therapy change (odds ratio 30.3, 95% confidence interval: 1.5-500, p=0.03). Conclusions: A constellation of motor and non-motor features may differentiate unmasked Parkinson's disease from drug-induced Parkinsonism. In particular, olfactory testing may offer a simple and inexpensive method to help predict outcomes in drug-induced Parkinsonism and, potentially, identify a cohort of pre-motor Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)738-742
Number of pages5
JournalParkinsonism and Related Disorders
Volume20
Issue number7
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Parkinsonian Disorders
Parkinson Disease
Pharmaceutical Preparations
Gait
Case-Control Studies
Facial Expression
Constipation
Odds Ratio
Confidence Intervals
Morbidity

Keywords

  • Drug-induced parkinsonism
  • Non-motor symptoms
  • Olfactory dysfunction
  • Parkinson's disease

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism. / Morley, James F.; Pawlowski, Stephanie M.; Kesari, Adhithi; Maina, Ivy; Pantelyat, Alexander; Duda, John E.

In: Parkinsonism and Related Disorders, Vol. 20, No. 7, 2014, p. 738-742.

Research output: Contribution to journalArticle

Morley, James F. ; Pawlowski, Stephanie M. ; Kesari, Adhithi ; Maina, Ivy ; Pantelyat, Alexander ; Duda, John E. / Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism. In: Parkinsonism and Related Disorders. 2014 ; Vol. 20, No. 7. pp. 738-742.
@article{ce45b1c2d0994e8193fd63171858c76b,
title = "Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism",
abstract = "Background: Drug-induced Parkinsonism is common, causes significant morbidity, and can be clinically indistinguishable from idiopathic Parkinson's disease. Additionally, drug-induced Parkinsonism may, in some cases, represent {"}unmasking{"} of incipient Parkinson's disease. Clinical features or tests that distinguish degenerative from pharmacologic Parkinsonism are needed. Methods: We performed a retrospective case-control study of 97 drug-induced Parkinsonism subjects and 97 age-matched patients with Parkinson's disease. We compared the frequency of subjective motor and non-motor complaints, objective motor findings (Unified Parkinson's Disease Rating Scale Part III) and, where available, objective olfactory tests. We also performed a nested case-control study wherein we compared these same features between drug-induced Parkinsonism patients based on whether or not they recovered after changing the offending agent. Results: Non-motor symptoms including constipation and sexual dysfunction were more common in Parkinson's disease than in drug-induced Parkinsonism. While total motor scores were similar between groups, Postural Instability-Gait Difficulty scores were also higher in Parkinson's disease. Features that were significantly different or showed a trend towards significance in both comparisons included subjective loss of facial expression, dream-enactment behavior, autonomic complaints and Postural Instability-Gait Difficulty scores. Hyposmia was more common in Parkinson's disease and was strongly predictive of persistent drug-induced Parkinsonism after therapy change (odds ratio 30.3, 95{\%} confidence interval: 1.5-500, p=0.03). Conclusions: A constellation of motor and non-motor features may differentiate unmasked Parkinson's disease from drug-induced Parkinsonism. In particular, olfactory testing may offer a simple and inexpensive method to help predict outcomes in drug-induced Parkinsonism and, potentially, identify a cohort of pre-motor Parkinson's disease.",
keywords = "Drug-induced parkinsonism, Non-motor symptoms, Olfactory dysfunction, Parkinson's disease",
author = "Morley, {James F.} and Pawlowski, {Stephanie M.} and Adhithi Kesari and Ivy Maina and Alexander Pantelyat and Duda, {John E.}",
year = "2014",
doi = "10.1016/j.parkreldis.2014.03.024",
language = "English (US)",
volume = "20",
pages = "738--742",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "7",

}

TY - JOUR

T1 - Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism

AU - Morley, James F.

AU - Pawlowski, Stephanie M.

AU - Kesari, Adhithi

AU - Maina, Ivy

AU - Pantelyat, Alexander

AU - Duda, John E.

PY - 2014

Y1 - 2014

N2 - Background: Drug-induced Parkinsonism is common, causes significant morbidity, and can be clinically indistinguishable from idiopathic Parkinson's disease. Additionally, drug-induced Parkinsonism may, in some cases, represent "unmasking" of incipient Parkinson's disease. Clinical features or tests that distinguish degenerative from pharmacologic Parkinsonism are needed. Methods: We performed a retrospective case-control study of 97 drug-induced Parkinsonism subjects and 97 age-matched patients with Parkinson's disease. We compared the frequency of subjective motor and non-motor complaints, objective motor findings (Unified Parkinson's Disease Rating Scale Part III) and, where available, objective olfactory tests. We also performed a nested case-control study wherein we compared these same features between drug-induced Parkinsonism patients based on whether or not they recovered after changing the offending agent. Results: Non-motor symptoms including constipation and sexual dysfunction were more common in Parkinson's disease than in drug-induced Parkinsonism. While total motor scores were similar between groups, Postural Instability-Gait Difficulty scores were also higher in Parkinson's disease. Features that were significantly different or showed a trend towards significance in both comparisons included subjective loss of facial expression, dream-enactment behavior, autonomic complaints and Postural Instability-Gait Difficulty scores. Hyposmia was more common in Parkinson's disease and was strongly predictive of persistent drug-induced Parkinsonism after therapy change (odds ratio 30.3, 95% confidence interval: 1.5-500, p=0.03). Conclusions: A constellation of motor and non-motor features may differentiate unmasked Parkinson's disease from drug-induced Parkinsonism. In particular, olfactory testing may offer a simple and inexpensive method to help predict outcomes in drug-induced Parkinsonism and, potentially, identify a cohort of pre-motor Parkinson's disease.

AB - Background: Drug-induced Parkinsonism is common, causes significant morbidity, and can be clinically indistinguishable from idiopathic Parkinson's disease. Additionally, drug-induced Parkinsonism may, in some cases, represent "unmasking" of incipient Parkinson's disease. Clinical features or tests that distinguish degenerative from pharmacologic Parkinsonism are needed. Methods: We performed a retrospective case-control study of 97 drug-induced Parkinsonism subjects and 97 age-matched patients with Parkinson's disease. We compared the frequency of subjective motor and non-motor complaints, objective motor findings (Unified Parkinson's Disease Rating Scale Part III) and, where available, objective olfactory tests. We also performed a nested case-control study wherein we compared these same features between drug-induced Parkinsonism patients based on whether or not they recovered after changing the offending agent. Results: Non-motor symptoms including constipation and sexual dysfunction were more common in Parkinson's disease than in drug-induced Parkinsonism. While total motor scores were similar between groups, Postural Instability-Gait Difficulty scores were also higher in Parkinson's disease. Features that were significantly different or showed a trend towards significance in both comparisons included subjective loss of facial expression, dream-enactment behavior, autonomic complaints and Postural Instability-Gait Difficulty scores. Hyposmia was more common in Parkinson's disease and was strongly predictive of persistent drug-induced Parkinsonism after therapy change (odds ratio 30.3, 95% confidence interval: 1.5-500, p=0.03). Conclusions: A constellation of motor and non-motor features may differentiate unmasked Parkinson's disease from drug-induced Parkinsonism. In particular, olfactory testing may offer a simple and inexpensive method to help predict outcomes in drug-induced Parkinsonism and, potentially, identify a cohort of pre-motor Parkinson's disease.

KW - Drug-induced parkinsonism

KW - Non-motor symptoms

KW - Olfactory dysfunction

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84902333935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902333935&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2014.03.024

DO - 10.1016/j.parkreldis.2014.03.024

M3 - Article

C2 - 24742370

AN - SCOPUS:84902333935

VL - 20

SP - 738

EP - 742

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 7

ER -